Two Sigma Investments’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
Two Sigma Investments's STSA Position: Q2 2023 in Review
Two Sigma Investments sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 297,129 shares — an estimated $208K sold.
Two Sigma Investments first reported a position in STSA in Q3 2020 and held it in 11 quarters. The position peaked at $2.12M in Q2 2021. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.
- Two Sigma Investments reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Two Sigma Investments sold 297,129 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $208K.
- Two Sigma Investments first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
- Two Sigma Investments's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $2.12M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.
Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.